DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 119 filers reported holding DYNE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 4.08 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $13 | +44.4% | 371 | +23.7% | 0.00% | – |
| Q1 2024 | $9 | +200.0% | 300 | +42.9% | 0.00% | – |
| Q4 2023 | $3 | +50.0% | 210 | 0.0% | 0.00% | – |
| Q3 2023 | $2 | 0.0% | 210 | 0.0% | 0.00% | – |
| Q2 2023 | $2 | 0.0% | 210 | 0.0% | 0.00% | – |
| Q1 2023 | $2 | 0.0% | 210 | 0.0% | 0.00% | – |
| Q4 2022 | $2 | -99.9% | 210 | +40.0% | 0.00% | – |
| Q3 2022 | $2,000 | +100.0% | 150 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 150 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -50.0% | 150 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | – | 150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FCPM III SERVICES B.V. | 7,845,364 | $276,862,896 | 40.83% |
| MPM ASSET MANAGEMENT LLC | 1,561,496 | $55,105,194 | 30.26% |
| Atlas Venture Life Science Advisors, LLC | 8,020,136 | $283,030,599 | 29.80% |
| Vida Ventures Advisors, LLC | 407,499 | $14,380,640 | 15.73% |
| TCG Crossover Management, LLC | 2,650,150 | $93,523,794 | 9.75% |
| Octagon Capital Advisors LP | 1,180,798 | $41,670,361 | 6.55% |
| ACUTA CAPITAL PARTNERS, LLC | 212,500 | $7,499,125 | 6.32% |
| Vivo Capital, LLC | 1,635,136 | $57,703,949 | 5.33% |
| VR Adviser, LLC | 2,173,913 | $76,717,390 | 4.89% |
| Deep Track Capital, LP | 4,000,000 | $141,160,000 | 4.21% |